Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.

Pepijn W A ThomasTessa E H RömkensRachel L WestMaurice G V M RusselJeroen M JansenJette A van LintNaomi T JessurunFrank Hoentjen

Published in: United European gastroenterology journal (2021)

IBD patients often report ADRs during biological therapy. We observed an important significant difference between the type and frequency of patient-reported ADRs versus HCP-reported ADRs, leading to an underestimation of more subjective ADRs and patients' ADR-related burden.

Keyphrases

end stage renal disease
healthcare
patient reported
newly diagnosed
ejection fraction
chronic kidney disease
adverse drug
prognostic factors
primary care
peritoneal dialysis
emergency department
patient reported outcomes
social media
case report
health information